医药行业分析
- (2024-08-01)
- (2024-08-01)
- (2024-08-01)
- (2024-08-01)
百奥赛图宣布与IDEAYA Biosciences就具有同类首创潜力的B7H3/PTK7拓扑异构酶抑制剂有效载荷双特异性ADC项目达成选择权和许可协议
(2024-08-01)- (2024-07-31)
- (2024-07-31)
- (2024-07-31)
- (2024-07-31)
- (2024-07-31)
- (2024-07-31)
- (2024-07-31)
- (2024-07-30)
- (2024-07-30)
- (2024-07-30)
- (2024-07-30)
- (2024-07-30)
- (2024-07-30)
- (2024-07-30)
- (2024-07-30)
- (2024-07-30)
- (2024-07-30)
- (2024-07-30)
- (2024-07-30)
- (2024-07-30)
- (2024-07-30)
- (2024-07-29)
- (2024-07-29)
- (2024-07-29)
- (2024-07-29)
- (2024-07-29)
- (2024-07-29)
- (2024-07-29)
- (2024-07-29)
- (2024-07-29)
- (2024-07-28)
- (2024-07-28)
- (2024-07-27)
- (2024-07-27)
- (2024-07-27)
- (2024-07-27)
- (2024-07-27)
- (2024-07-26)
- (2024-07-26)
- (2024-07-26)
- (2024-07-26)
- (2024-07-26)
- (2024-07-26)
- (2024-07-26)
- (2024-07-25)
- (2024-07-25)
- (2024-07-25)
- (2024-07-25)
- (2024-07-25)
- (2024-07-25)
《自然·医学》:治疗衰老,可能要看条件!临床试验结果显示,达沙替尼+槲皮素治疗老年女性骨质流失,衰老细胞负荷高,骨骼改善效果好
(2024-07-25)- (2024-07-24)
- (2024-07-24)
- (2024-07-24)
- (2024-07-24)